4//SEC Filing
Anderson Karen M. 4
Accession 0001847903-25-000026
CIK 0001847903other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:56 PM ET
Size
9.6 KB
Accession
0001847903-25-000026
Insider Transaction Report
Form 4
Anderson Karen M.
Chief People Officer
Transactions
- Tax Payment
Ordinary Shares
2025-02-01$16.92/sh−10,732$181,585→ 60,793 total - Sale
Ordinary Shares
2025-02-03$16.86/sh−6,471$109,124→ 54,322 total - Award
Share Option (right to buy)
2025-02-03+120,000→ 120,000 totalExercise: $16.90Exp: 2035-02-03→ Ordinary Shares (120,000 underlying)
Footnotes (5)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
- [F3]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2024.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.22 to $17.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 3, 2025.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001762176
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:56 PM ET
- Size
- 9.6 KB